Source-specific fine particulate air pollution and systemic inflammation in ischaemic heart disease patients

Occupational and Environmental Medicine

Volumn 72, Issue 4, 2015, Pages 277-283

  Siponen, Taina ^a   Yli Tuomi, Tarja ^a   Aurela, Minna ^b   Dufva, Hilkka ^c   Hillamo, Risto ^b   Hirvonen, Maija Riitta ^a,d   Huttunen, Kati ^d   Pekkanen, Juha ^a,e   Pennanen, Arto ^a   Salonen, Iiris ^f   Tiittanen, Pekka ^a   Salonen, Raimo O ^a   Lanki, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH METEOROLOGICAL INSTITUTE   (Finland)

^c Building Services and Material Technology   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Kymenlaakso Hospital Services   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 12; MYELOPEROXIDASE; BIOLOGICAL MARKER; CYTOKINE; PARTICULATE MATTER;

ADULT; AGED; AIR POLLUTION; ARTICLE; BIOMASS; BLOOD SAMPLING; COMBUSTION; DISEASE MARKER; ENVIRONMENTAL PROTECTION; EXHAUST GAS; FEMALE; FINLAND; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARTICULATE MATTER; PRIORITY JOURNAL; PULPING; SEA; ADVERSE EFFECTS; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; CAUSALITY; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; LUMINESCENCE; MYOCARDIAL ISCHEMIA; PHOTOMETRY; RISK FACTOR; TOXICITY;

AIR POLLUTION; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSALITY; CYTOKINES; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FINLAND; HUMANS; INFLAMMATION; LUMINESCENCE; MYOCARDIAL ISCHEMIA; NEPHELOMETRY AND TURBIDIMETRY; PARTICULATE MATTER; RISK FACTORS;

EID: 84925100965     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2014-102240     Document Type: Article

References (41)

1. Brook RD, Rajagopalan S, Pope CA III, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010;121:2331-78.
2. Pope CA III, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc 2006;56:709-42.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
4. Janssen NAH, Gerlofs-Nijland ME, Lanki T, et al. Health effects of black carbon. Copenhagen Ø, Denmark: World Health Organization, 2012.
5. Naeher LP, Brauer M, Lipsett M, et al. Woodsmoke health effects: a review. Inhal Toxicol 2007;19:67-106.
6. WHO. Review of evidence on health aspects ofair pollution-REVIHAAP Project: final technical report. 2013.
7. Huttunen K, Siponen T, Salonen I, et al. Low-level exposure to ambient particulate matter is associated with systemic inflammation in ischemic heart disease patients. Environ Res 2012;116:44-51.
8. Peters A, Schneider A, Greven S, et al. Air pollution and inflammatory response in myocardial infarction survivors: gene-environment interactions in a high-risk group. Inhal Toxicol 2007;19:161-75.
9. 2.5 well impactor ninety-six (WINS). Aerosol Sci Technol 2001;34:389-97.
10. ISO 9835. Ambient air-determination of a black smoke index. 1993.
11. Dye C, Yttri KE. Determination of monosaccharide anhydrides in atmospheric aerosols by use of high-performance liquid chromatography combined with high-resolution mass spectrometry. Anal Chem 2005;77:1853-8.
12. Aurela M, Sillanpää M, Pennanen A, et al. Characterization of urban particulate matter for a health-related study in southern Finland. Boreal Env Res 2010;15:513-32.
13. Greven S, Küchenhoff H, Peters A. Additive mixed models with P-splines. Proceedings of the 21st International workshop on Statistical Modelling. 2006;201-7.
14. Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009;53:317-33.
15. Delfino RJ, Staimer N, Tjoa T, et al. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 2008;116:898-906.
16. Pope CA III, Hansen ML, Long RW, et al. Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect 2004;112:339-45.
17. Ruckerl R, Ibald-Mulli A, Koenig W, et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 2006;173:432-41.
18. Zhang X, Niessner A, Nakajima T, et al. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 2006;98:524-31.
19. Meuwese MC, Stroes ES, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-65.
20. Zhang R, Brennan M, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136.
21. Pekkanen J, Brunner EJ, Anderson HR, et al. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med 2000;57:818-22.
22. Ruckerl R, Greven S, Ljungman P, et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007;115:1072-80.
23. Seaton A, Soutar A, Crawford V, et al. Particulate air pollution and the blood. Thorax 1999;54:1027-32.
24. Chen JC, Schwartz J. Metabolic syndrome and inflammatory responses to long-term particulate air pollutants. Environ Health Perspect 2008;116:612-17.
25. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-8.
26. Bruske I, Hampel R, Socher MM, et al. Impact of ambient air pollution on the differential white blood cell count in patients with chronic pulmonary disease. Inhal Toxicol 2010;22:245-52.
27. Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ Health Perspect 2001;109:405-9.
28. Ojanen C, Pakkanen T, Aurela M, et al. Hengitettävien hiukkasten kokojakauma, koostumus ja lähteet pääkaupunkiseudulla [In Finnish, abstract in English]. 1998;7.
29. Saarnio K, Niemi JV, Saarikoski S, et al. Using monosaccharide anhydrides to estimate the impact of wood combustion on fine particles in the Helsinki Metropolitan Area. Boreal Environ Res 2012;17:163.
30. 2.5 and daily mortality in Phoenix, AZ. J Expo Sci Environ Epidemiol 2006;16:311-20.
31. Sarnat JA, Marmur A, Klein M, et al. Fine particle sources and cardiorespiratory morbidity: An application of chemical mass balance and factor analytical source-apportionment methods. Environ Health Perspect 2008;116:459-66.
32. Morawska L, Ristovski Z, Jayaratne ER, et al. Ambient nano and ultrafine particles from motor vehicle emissions: Characteristics, ambient processing and implications on human exposure. Atmos Environ 2008;42:8113-38.
33. Shi JP, Khan AA, Harrison RM. Measurements of ultrafine particle concentration and size distribution in the urban atmosphere. Sci Total Environ 1999;235:51-64.
34. Hildebrandt K, Ruckerl R, Koenig W, et al. Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol 2009;6:25.
35. Hennig F, Fuks K, Moebus S, et al. Association between source-specific particulate matter air pollution and hs-CRP: local traffic and industrial emissions. Environ Health Perspect 2014;122:703-10.
36. Janssen NAH, Hoek G, Harssema H, et al. Personal exposure to fine particles in children correlates closely with ambient fine particles. Arch Environ Health 1999;54:95-101.
37. Janssen NAH. Associations between ambient, personal, and indoor exposure to fine particulate matter constituents in Dutch and Finnish panels of cardiovascular patients. Occup Environ Med 2005;62:868.
38. Sarnat JA, Koutrakis P, Suh HH. Assessing the relationship between personal particulate and gaseous exposures of senior citizens living in Baltimore, MD. J Air Waste Manage Assoc 2000;50:1184-98.
39. 2.5 elemental concentrations with indoor and personal concentrations. Atmos Environ 2014;86:203-11.
40. Yli-Tuomi T, Lanki T, Hoek G, et al. Determination of the sources of indoor PM (2.5) in Amsterdam and Helsinki. Environ Sci Technol 2008;42:4440-6.
41. 2.5 exposure of pregnant women in Barcelona, Spain. Atmos Environ 2012;59:426-36.